The global hepatitis
diagnostics market is expected to reach USD 6.9 billion by 2025,
according to a new report by Grand View Research, Inc. In the past decade, the
burden of hepatitis A, B & C has significantly increased compared to that
of type D & E. In addition, in emerging countries, around 90% of the
children (below 10 years of age) are infected with type A virus as stated by
the WHO reports. These reports also state that in 2016, around 71 million
people were affected by the hepatitis C and 257 million people were suffering
from type B infection.
The non-government and government organizations play a
vital role in increasing awareness of infectious diseases by conducting
campaigns in order to deliver correct knowledge about the symptoms, condition,
and detection techniques. Thereby, rendering a positive impact on the market
growth owing to rising demand for diagnostic tests. Furthermore, the adoption of
molecular biology techniques and other technologically advanced detection
techniques are spurring the market growth.
Browse full research report on Hepatitis Diagnostic Test Market: https://www.grandviewresearch.com/industry-analysis/hepatitis-diagnostic-test-market
Further
key findings from the study suggest:
- The blood tests segment dominate the market and is expected to
exhibit the fastest growth rate over the forecast period owing to their
higher adoption as a first line of diagnosis.
- The liver function tests, sub type of blood test hold a significant
share of the market since these tests are the first line diagnostics and
are prerequisite for further analytical examinations required to performed
for confirmation of virus causing the disease
- North America dominated with largest revenue share in 2016, owing
to rising prevalence, various government initiatives creating awareness
regarding rising incidences, and highly developed healthcare
infrastructure
- Constant rise in the new cases of hepatitis is observed in Asia
Pacific. Thus, this region is expected to witness a rapid growth during
the forecast period.
- Some of the major players competing include, but are not limited to
Abbott Laboratories; Danaher Corporation; F. Hoffmann Roche; DiaSorin
S.p.A; MedMira, Inc.; Siemens Ag, bioMeriuex SA; Hologic, Inc.; and Bio
Rad Laboratories.
- These players dominate the market with their strong brand identity
and extensive geographic reach by their strategic initiatives such as
mergers & acquisition and partnership with other players.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand
View Research has segmented the hepatitis diagnostics test market report on the
basis of diagnostic tests and region:
Diagnostic
Tests Outlook (Revenue, USD Million; 2014 - 2025)
- Blood tests
- Liver
function tests
- Immunoassays
- Nucleic Acid
Tests
- Imaging Tests
- Liver Biopsy
Regional
Outlook (Revenue, USD Million; 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment